erratum

1
28-NIGHT INSQtv1NIA RELIEF.:. PKOVED BY THE POLYGRAPH, CORROBORATED BY THE PATIENTS 2 DALMANE® (flurazepam Hen One ](>orne capsule h.s. - usual adult doUIp U5 mg may suffice in some patients). One 15-me capsule h.s. recommetlded doup for ekIerIy or debllltMed p8tIents. Before presc:ribinc Dall11lne (flurazepam Hel), please consult product information, a summary 01 which follows: Indications: Effective in all types of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings and/or early morning awakening; in patients with recurring insomnia or poor sleeping habits; in acute or chronic medical situations re- quiri ng restful sleep. Objective sleep laboratory data haveshown effectiveness for at least 28 consecutive nights of administration. Since insomnia is often transient and intermittent, prolonged administration is generally not necessary or recommended. Contraindications: Known hypersensitivity to flurazepam HCI. Wtminp: Caution patients about possible combined effects with alcohol and other CNS depressants. Caution against hazardous occupations requiring complete mental alertness (e.g., operating machinery, driving). Us8ge in Pregnancy: Several studies 01 minortranquilizers meprobamate) suaest increased nsk 01 concenital malfonnations durinc the first trimester 01 prepancy. Dalmane, a benzodiazepine, has not been studied to determine whether it may be associated with such an Increased risk. Because use 01 these drugs is rarely a matter 01 urgency, their use durinc this period should almost always be avoided. C0n- sider possibility 01 pregnancy when institutinc therapy; advise patients to discuss therapy if they intend to or do become prepant. Not recommended for use in persons under 15 years of age. Though physical and psychological dependence have not been reported on recommended doses, use caution in administering to addiction-prone individuals or those who might increase dosage. Precautions: In elderly and debilitated, limit dosage to 15 mg to reduce risk of oversedation, dizziness, confusion and/or ataxia. Consider potential additive effects with other hypnotics or CNS depressants. Employ usual precautions in patients who are se- verely depressed, or with latent depression or suicidal tendencies, or with impaired renal or hepatic function. Periodic blood counts and liver and kidney function tests are advised during repeated therapy. Adverse Reactions: Dizziness, drowsiness, Iightheadedness, staggering, ataxia and falling have occurred, particularly in elderly or debilitated patients. Severe sedation, lethargy, disorientation and coma, probably indicative of drug intolerance or overdosage, have been reported. Also reported: headache, heartburn, upset stomaCh, nausea, vomiting, diarrhea, constipation, GI pain, ner- vousness, talkativeness, apprehension, irritability, weakness, palpitations, chest pains, body and joint pains and GU complaints. There have also been rare occurrences of leukopenia, granulo- cytopenia, sweating, flushes, difficulty in focusing, blurred vision, burning eyes, faintness, hypotension, shortness of breath, pruritus, skin rash, dry mouth, bitter taste, excessive salivation, anorexia, euphoria, depression, slurred speech, confusion, rest- lessness, hallucinations, paradoxical reactions, e.g., excitement. stimulation and hyperactivity, and elevated SGOT, SGPT, total and direct bilirubins and alkaline phosphatase. Dosage: Individualize for maximum beneficial effect. Adults: 30 mg usual dosage; 15 mg may suffice in some patients. Elderly or debilitated patients: 15 mg initially until response is determined. Supplied: Capsules containing 15 mg or 30 mg flurazepam HCI. REFERENCES: 1. Kales A, et al: Clin Pharmacol Ther 19:576-583, May 1976 2. Dement WC, Guilleminault C, Zarcone V: Progress in clinical sleep research. Scientific exhibit at the American Medical Association, Atlantic City NJ, Jun 14-18, 1975 /IiiiC;\ BOOK REVIEWS Controversy in Psychiatry Edited by John Paul Brady and H. Keith H. Brodie, 1087 pp, $39.50, Philadelphia, Saunders, 1978. It was time for a book like this to be published, for controversy in and about psychiatry abounds. Questions have been asked for the last decade as to whether or not psychiatry should exist and what its function is. Some psychiatrists have been told by other mental health workers that they knew as much as the .psychiatrists and the latter's only function was to sign prescrip- tions. Psychologists say that psy- chiatrists practice psychology, for which they are not trained, and do not practice medicine, for which they are trained. Obviously, a book like this that examines various phases of this controversy is needed. The editors chose 26 topics that needed to be aired and had them discussed, pro and con, by knowl- edgeable individuals, with the two editors appending a comment to each chapter. Incidentally, the 26 topics cover most of the problems that agitate the specialty today, and the editors were fortunate to be able to attract such a high caliber of Erratum In the November 1978 issue of Psychosomatics, Figure 2 in the ar- ticle "Ventricular premature beats, stress, and sudden death" was re- produced with permission from DeSilva RA, Verrier RL, and Lown B, Am Heart J 95:197, 1978. The editors regret this omission. PSYCHOSOMATICS

Upload: vuongque

Post on 30-Dec-2016

219 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Erratum

28-NIGHT INSQtv1NIA RELIEF.:.PKOVED BY THE POLYGRAPH,CORROBORATED BY THE PATIENTS2

DALMANE®(flurazepam Hen

One ](>orne capsule h.s. - usual adult doUIpU5 mg may suffice in some patients).One 15-me capsule h.s. recommetlded doupfor ekIerIy or debllltMed p8tIents.

Before presc:ribinc Dall11lne (flurazepam Hel), please consultco~eproduct information, a summary 01 which follows:Indications: Effective in all types of insomnia characterized bydifficulty in falling asleep, frequent nocturnal awakenings and/orearly morning awakening; in patients with recurring insomnia orpoor sleeping habits; in acute or chronic medical situations re­quiri ng restful sleep. Objective sleep laboratory data have showneffectiveness for at least 28 consecutive nights of administration.Since insomnia is often transient and intermittent, prolongedadministration is generally not necessary or recommended.Contraindications: Known hypersensitivity to flurazepam HCI.Wtminp: Caution patients about possible combined effects withalcohol and other CNS depressants. Caution against hazardousoccupations requiring complete mental alertness (e.g., operatingmachinery, driving).

Us8ge in Pregnancy:Several studies01 minortranquilizers(chlord~xide,diazeP.am,andmeprobamate)suaestincreased nsk 01 concenital malfonnationsdurincthe firsttrimester 01 prepancy. Dalmane, a benzodiazepine, hasnot been studiedadeq~to determine whether it maybe associated with such an Increased risk. Because use01 these drugs is rarely a matter 01 urgency, their usedurinc this period should almost always be avoided. C0n­sider possibility 01 pregnancy when institutinc therapy;advise patients to discuss therapy if they intend to ordo become prepant.

Not recommended for use in persons under 15 years of age.Though physical and psychological dependence have not beenreported on recommended doses, use caution in administering toaddiction-prone individuals or those who might increase dosage.Precautions: In elderly and debilitated, limit dosage to 15 mgto reduce risk of oversedation, dizziness, confusion and/or ataxia.Consider potential additive effects with other hypnotics or CNSdepressants. Employ usual precautions in patients who are se­verely depressed, or with latent depression or suicidal tendencies,or with impaired renal or hepatic function. Periodic bloodcounts and liver and kidney function tests are advised duringrepeated therapy.Adverse Reactions: Dizziness, drowsiness, Iightheadedness,staggering, ataxia and falling have occurred, particularly in elderlyor debilitated patients. Severe sedation, lethargy, disorientationand coma, probably indicative of drug intolerance or overdosage,have been reported. Also reported: headache, heartburn, upsetstomaCh, nausea, vomiting, diarrhea, constipation, GI pain, ner­vousness, talkativeness, apprehension, irritability, weakness,palpitations, chest pains, body and joint pains and GU complaints.There have also been rare occurrences of leukopenia, granulo­cytopenia, sweating, flushes, difficulty in focusing, blurred vision,burning eyes, faintness, hypotension, shortness of breath,pruritus, skin rash, dry mouth, bitter taste, excessive salivation,anorexia, euphoria, depression, slurred speech, confusion, rest­lessness, hallucinations, paradoxical reactions, e.g., excitement.stimulation and hyperactivity, and elevated SGOT, SGPT, total anddirect bilirubins and alkaline phosphatase.Dosage: Individualize for maximum beneficial effect.Adults: 30 mg usual dosage; 15 mg may suffice in some patients.Elderly or debilitated patients: 15 mg initially until responseis determined.Supplied: Capsules containing 15 mg or 30 mg flurazepam HCI.

REFERENCES:1. Kales A, et al: Clin Pharmacol Ther 19:576-583, May 19762. Dement WC, Guilleminault C, Zarcone V: Progress in clinicalsleep research. Scientific exhibit at the American MedicalAssociation, Atlantic City NJ, Jun 14-18, 1975

/IiiiC;\ ~.'!~!:!~ ~~?2Y£~~ ~S~,

BOOKREVIEWSControversy in PsychiatryEdited by John Paul Brady and H. Keith H.Brodie, 1087 pp, $39.50, Philadelphia,Saunders, 1978.

• It was time for a book like this tobe published, for controversy inand about psychiatry abounds.Questions have been asked for thelast decade as to whether or notpsychiatry should exist and what itsfunction is. Some psychiatrists havebeen told by other mental healthworkers that they knew as much asthe .psychiatrists and the latter'sonly function was to sign prescrip­tions. Psychologists say that psy­chiatrists practice psychology, forwhich they are not trained, and donot practice medicine, for whichthey are trained. Obviously, a booklike this that examines variousphases of this controversy isneeded.

The editors chose 26 topics thatneeded to be aired and had themdiscussed, pro and con, by knowl­edgeable individuals, with the twoeditors appending a comment toeach chapter. Incidentally, the 26topics cover most of the problemsthat agitate the specialty today, andthe editors were fortunate to beable to attract such a high caliber of

Erratum

In the November 1978 issue ofPsychosomatics, Figure 2 in the ar­ticle "Ventricular premature beats,stress, and sudden death" was re­produced with permission fromDeSilva RA, Verrier RL, and LownB, Am Heart J 95:197, 1978. Theeditors regret this omission.

PSYCHOSOMATICS